61.08 USD
↘ 0.38 (0.62%)PRE MARKET (AS OF 09:16 AM EDT)
Bristol-Myers Squibb Co. (BMY) trades at $61.08 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include exceptional Return on Equity (41.6%) and a bullish Golden Cross on the moving averages. On the valuation side, BMY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 1, 2026.